Diagnosis of Central Precocious Puberty
Copyright © 2024 Elsevier Inc. All rights reserved..
A thorough history and physical examination including Tanner staging and growth assessments can guide differential diagnosis and aid in the evaluation of precocious puberty. Basal luteinizing hormone levels measured using a highly sensitive assay can be helpful in diagnosing central precocious puberty (CPP). Brain MRI is indicated with males diagnosed with CPP and females under the age of 6 with CPP. As more information becomes available regarding the genetic etiologies of CPP, genetic testing may preclude the need for imaging studies and other hormonal testing, especially in familial cases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Endocrinology and metabolism clinics of North America - 53(2024), 2 vom: 27. Apr., Seite 217-227 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bangalore Krishna, Kanthi [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.04.2024 Date Revised 27.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ecl.2024.02.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM371667070 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM371667070 | ||
003 | DE-627 | ||
005 | 20240428232423.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240428s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ecl.2024.02.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1391.xml |
035 | |a (DE-627)NLM371667070 | ||
035 | |a (NLM)38677865 | ||
035 | |a (PII)S0889-8529(24)00013-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bangalore Krishna, Kanthi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnosis of Central Precocious Puberty |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.04.2024 | ||
500 | |a Date Revised 27.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | |a A thorough history and physical examination including Tanner staging and growth assessments can guide differential diagnosis and aid in the evaluation of precocious puberty. Basal luteinizing hormone levels measured using a highly sensitive assay can be helpful in diagnosing central precocious puberty (CPP). Brain MRI is indicated with males diagnosed with CPP and females under the age of 6 with CPP. As more information becomes available regarding the genetic etiologies of CPP, genetic testing may preclude the need for imaging studies and other hormonal testing, especially in familial cases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Bone age | |
650 | 4 | |a Brain MRI | |
650 | 4 | |a Central precocious puberty | |
650 | 4 | |a Gonadotropin-releasing hormone analogue | |
650 | 4 | |a Pelvic ultrasound | |
650 | 4 | |a Peripheral precocious puberty | |
650 | 4 | |a Precocious puberty | |
650 | 7 | |a Luteinizing Hormone |2 NLM | |
650 | 7 | |a 9002-67-9 |2 NLM | |
700 | 1 | |a Silverman, Lawrence A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Endocrinology and metabolism clinics of North America |d 1996 |g 53(2024), 2 vom: 27. Apr., Seite 217-227 |w (DE-627)NLM013004832 |x 1558-4410 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2024 |g number:2 |g day:27 |g month:04 |g pages:217-227 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ecl.2024.02.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 53 |j 2024 |e 2 |b 27 |c 04 |h 217-227 |